about
DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formationImpairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron diseaseHuman peroxiredoxin 5 is a peroxynitrite reductaseDJ-1 induces thioredoxin 1 expression through the Nrf2 pathwayApolipoprotein D is involved in the mechanisms regulating protection from oxidative stressOlesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosisImplications of glial nitric oxide in neurodegenerative diseasesSepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the ElderlyHsp70.1 and related lysosomal factors for necrotic neuronal deathMitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingProtein carbonylation, cellular dysfunction, and disease progressionOxidative stress and severe walking disability among older womenMultiple measures of functionality exhibit progressive decline in a parallel, stochastic fashion in Drosophila Sod2 null mutantsPhosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effectsOxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formationEvidence for oxidative stress in the developing cerebellum of the rat after chronic mild carbon monoxide exposure (0.0025% in air)Rapid purification and mass spectrometric characterization of mitochondrial NADH dehydrogenase (Complex I) from rodent brain and a dopaminergic neuronal cell line.Protein disulfide bond formation in the cytoplasm during oxidative stress.Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseasesAge-related alterations in oxidatively damaged proteins of mouse skeletal muscle mitochondrial electron transport chain complexes.Involvement of Nrf2 in Ocular Diseases.Malondialdehyde suppresses cerebral function by breaking homeostasis between excitation and inhibition in turtle Trachemys scriptaSerum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.Aberrant topoisomerase-1 DNA lesions are pathogenic in neurodegenerative genome instability syndromesRole of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosisAntioxidant effects of Etlingera elatior flower extract against lead acetate - induced perturbations in free radical scavenging enzymes and lipid peroxidation in ratsLifelong calorie restriction alleviates age-related oxidative damage in peripheral nerves.Burn serum causes a CD14-dependent mitochondrial damage in primary cardiomyocytesNeuroprotective effects of cuscutae semen in a mouse model of Parkinson's disease.Mitochondrial pathobiology in ALS.Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis.Cerium oxide nanoparticles protect against Aβ-induced mitochondrial fragmentation and neuronal cell death.Astrocytes and therapeutics for Parkinson's disease.Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.Targeting NOX enzymes in the central nervous system: therapeutic opportunities.A comparative 'bottom up' proteomics strategy for the site-specific identification and quantification of protein modifications by electrophilic lipids.Induced pluripotent stem cells without c-Myc ameliorate retinal oxidative damage via paracrine effects and reduced oxidative stress in rats.Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria
P2860
Q21146396-F3375366-1C85-40AD-B2E2-2C6A97278839Q21262978-B67AD17C-D21C-4DE8-ABD6-A877F7287EB2Q24300171-E509BA76-24C5-41DC-B7E0-3D76820E610AQ24312506-833883E1-5232-4674-A0BF-BC1217C7AEF1Q24322820-51990971-0EDA-4F3E-82ED-E6189D446799Q24596378-C0450920-D758-4518-BC90-A595562BFA38Q26782894-5E682323-BBCF-449E-97C7-58F70899C1A5Q26853544-8A960489-CCEF-4C69-A398-25ED891E2202Q27012978-37FE1DEB-3C9A-4989-B5E2-6EBDFBF41286Q27013585-347234FE-B98E-4933-86C7-EE509D127694Q28076999-B09152D9-F30F-4164-B19A-905CE213BCF5Q28248107-E36FCF20-5421-4FD4-B434-F7DC7CFB6224Q28260066-CC60C930-6779-46C5-B775-A6C7D2B91F2AQ28306903-E728D26A-6F8B-47E9-9E09-85E8A3AF4FF4Q28482353-3EF03399-C40E-4984-8234-C6A46BC0FABBQ28538487-B1F7831E-4B22-46F7-ACC3-9023A80402A1Q28580983-82167B8B-387F-49F3-975E-F22AB55B2196Q31135400-3B60EAD4-A02E-4D53-8D81-53E62D2CCDDFQ33199830-C899E196-6D0F-4928-ABEA-2940529D02D9Q33235503-E9EBC3E1-0DD3-4565-9FFE-27D16DFA62EDQ33348887-0F982366-3437-4158-AAD6-C3324D62240AQ33573617-54ED5579-6516-4F7D-8B17-A37EF44052EFQ33784778-763EA413-2BED-47BD-891C-63D0A0F28172Q33785724-5CF387F6-8C60-4A7E-85A8-C1AE6747162DQ33816985-E38FD39F-39FC-4C9D-BC86-55F55409BD38Q33819255-CF35D436-65EE-41FB-8067-34516C236752Q33849443-1C362A92-A994-454B-B1E5-6BD121DD1EE0Q33879901-8E128729-B3B9-4B35-BF48-E221DB79EF14Q33917121-8FF6BB55-CE8D-485E-9BF1-AFEF0D17FB38Q34032558-246ABE11-105D-40F9-8CBD-98AE4B532B35Q34038775-4E8D533C-6994-4F46-9380-54204051D41AQ34133422-BDC48311-610D-495A-BD57-4481A478B0DBQ34153527-4F50AC95-BF82-4A05-B409-8E6FCD4E5FF7Q34168266-CA02B50E-1C10-4E33-BBB6-70C3A63F3A54Q34246134-4D8228BC-6CD2-43A9-BA22-6D1BDA123052Q34285497-5016514D-B1C7-4B98-9380-B90EA19C374FQ34355548-1289AA5B-E33C-4D4D-8B4C-5FAD892FBA52Q34454918-324FB6B8-887B-4577-B06B-F91E35EC7E82Q34502221-5C6A9D2C-F85A-4119-BF30-F45AC10B4D53Q34565165-B8B5C327-72C5-4548-84A8-29FCDD5DF4DA
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Oxidatively modified proteins in aging and disease.
@ast
Oxidatively modified proteins in aging and disease.
@en
Oxidatively modified proteins in aging and disease.
@nl
type
label
Oxidatively modified proteins in aging and disease.
@ast
Oxidatively modified proteins in aging and disease.
@en
Oxidatively modified proteins in aging and disease.
@nl
prefLabel
Oxidatively modified proteins in aging and disease.
@ast
Oxidatively modified proteins in aging and disease.
@en
Oxidatively modified proteins in aging and disease.
@nl
P1476
Oxidatively modified proteins in aging and disease.
@en
P2093
M Flint Beal
P304
P356
10.1016/S0891-5849(02)00780-3
P577
2002-05-01T00:00:00Z